Mongolia: Strengthening Health Security Program (Subprogram 1)
The proposed program aims to strengthen the health sector's response to the coronavirus disease (COVID-19) pandemic and expedite the medium-term reforms that will strengthen the health system and help Mongolia become better prepared to respond to future health crises. The program's design draws on the operational knowledge that the Asian Development Bank (ADB) has gained through its engagement in the health sector in Mongolia since 1993. Through a strategic, coordinated, and well-sequenced set of policy actions, the program will facilitate both immediate and critical medium-term reforms. The provision of a $100 million loan will directly contribute to address the urgent financing needs of the Government of Mongolia.
East Asia Department
Request for information
|Project Name||Strengthening Health Security Program (Subprogram 1)|
|Country / Economy||Mongolia
|Project Type / Modality of Assistance||Loan
|Source of Funding / Amount||
|Strategic Agendas||Inclusive economic growth
|Drivers of Change||Gender Equity and Mainstreaming
Governance and capacity development
|Sector / Subsector||
Health / Disease control of communicable disease - Health sector development and reform - Health system development
|Gender Equity and Mainstreaming||Effective gender mainstreaming|
|Description||The proposed program aims to strengthen the health sector's response to the coronavirus disease (COVID-19) pandemic and expedite the medium-term reforms that will strengthen the health system and help Mongolia become better prepared to respond to future health crises. The program's design draws on the operational knowledge that the Asian Development Bank (ADB) has gained through its engagement in the health sector in Mongolia since 1993. Through a strategic, coordinated, and well-sequenced set of policy actions, the program will facilitate both immediate and critical medium-term reforms. The provision of a $100 million loan will directly contribute to address the urgent financing needs of the Government of Mongolia. Four reform areas identified under the program will focus on (i) strengthening planning and preparedness of the health sector, and ensuring the availability of critical medicines and emergency supplies; (ii) improving national pharmaceutical regulation, and increasing hospital autonomy and good governance; (iii) enhancing procurement in the health sector to increase efficiency, and establishing a single purchaser for health services; and (iv) safeguarding fiscal sustainability of the government over the medium term (3-5 years).|
|Project Rationale and Linkage to Country/Regional Strategy||
Deep economic contraction because of COVID-19. Mongolia's economy contracted by 5.3% in 2020 year-over-year (YoY) reflecting the severe impact of COVID-19 on the Mongolian economy. The mining industry contracted by 9.4% in 2020 because of substantially lower export demand. This spilled over to other sectors, with only agriculture and manufacturing not contracting. On the demand side, private consumption, government consumption, and net exports all grew, but investment dragged growth down significantly by 19.1 percentage points. In 2020, the current account deficit fell by 73.3% YoY to 4.4% of gross domestic product (GDP), though the financial account surplus shrank by 48.1% YoY to 10.6% of GDP, resulting in a balance-of-payments surplus of $787 million. Revenues will fall by 16.8% for 2020, while expenditure will rise by 5.1%. Compared to the pre-COVID-19 plan, the overall fiscal balance will deteriorate to 9.9% of the GDP and the structural fiscal balance will deteriorate to 12.5% of the GDP.
Government remains committed to macroeconomic reform. According to the International Monetary Fund (IMF) assessment letter, Mongolia continues to face three key macroeconomic challenges: (i) high public debt, (ii) low foreign exchange reserves, and (iii) insufficient capital buffers in banks. On the fiscal side, the government reduced the debt-to-GDP ratio from 109.1% in 2016 to 79.1% in 2019. Fiscal pressures because of COVID-19 will increase debt by 14.5 percentage points in 2020, but the downward trajectory of the debt-to-GDP ratio will return with the resumption of growth in 2021. Further, under reform area 4 of the program, the government has committed to reduce the structural deficit to 5.1% in 2021, in line with the fiscal consolidation plans under the Fiscal Stability Law, 2010. Gross reserves increased from 2.8 months of goods and services imports at the end of 2016 to 5.8 months at the end of 2019. According to the IMF, the level of reserves is sufficient to limit the risk of a capital account crisis, but risks relating to upcoming debt repayments remain. The recapitalization of the banking sector remains an outstanding issue and has been made worse by the COVID-19 pandemic. The appropriate measures taken by the Bank of Mongolia to respond to the pressures of the COVID-19 pandemic did limit the burden on firms and households, but it will be important to exit from these measures carefully as the COVID-19 pandemic recedes, closely monitor capital adequacy in selected banks, and act decisively if banks face liquidity pressures again.
Decisive response to COVID-19 pandemic initially prevented large-scale community transmission. The government initiated stringent emergency measures to prevent the spread of the COVID-19 pandemic in Mongolia. These measures included international and national travel restrictions; the closure of nonessential businesses; public awareness campaigns focused on containing the spread of the virus; preparation of hospitals to manage emergencies in the event of a surge in infected patients; restrictions on public gatherings, meetings, and celebrations; and the closure of schools. These actions delayed community spread, and Mongolia only recorded the first case of locally transmitted COVID-19 on 11 November 2020. As of 28 February 2021, the total number of cases was 2,907, of which 414 were imported, with 4 deaths. Since 12 November 2020, the country has initiated several national lockdowns as the government undertakes contact tracing, testing, and containment policies. The most recent lockdown ended on 23 February 2021.
Significant progress in improving health outcomes in recent years. The average life expectancy at birth increased to 70 years in 2018, up from 69 in 2016. Mongolia achieved its Millennium Development Goal targets in 2015 for maternal and child mortality. The infant mortality rate decreased to 14 per 1,000 live births in 2018 from 16 per 1,000 live births in 2015, and the under-5 mortality rate decreased to 16 per 1,000 live births in 2018 from 19 per 1,000 live births in 2015. Similarly, the maternal mortality ratio decreased to 45 per 100,000 live births in 2017 from 51 per 100,000 live births in 2013.
Community transmission is straining the health sector. The government estimates about 60% of the population is at high risk of infection. A surge in infections would result in a shortage of quarantine facilities, necessary equipment, drugs, and other essential resources. A 2017 World Health Organization evaluation concluded that Mongolia's core capacities relating to pandemic preparedness are limited, suggesting Mongolia is ill prepared for a surge of COVID-19 or a similar pandemic. Mongolia's National Emergency Management Agency has a disaster management plan, but this plan does not clearly define the roles and responsibilities of other involved national agencies. The evaluation concluded that Mongolia remains vulnerable to emerging diseases and public health emergencies, and challenges exist in the national system's readiness to respond to large-scale and complex events in an effective and coordinated way. Systemic health sector constraints are also further amplified during health crises. Under reform area 1, several policy actions are introduced to strengthen Mongolia's immediate response capacity in relation to COVID-19 pandemic and possible similar future health crises. A number of health sector inefficiencies persist that affect the quality of health services provided.
COVID-19 pandemic accentuates ineffective and inefficient governance arrangements around public hospitals that weaken treatment capacities. Rigid line-item budgeting in public hospitals is an important source of inefficiency in the management and financing of hospitals. Input-based budgeting is poorly linked to the actual costs and volume of services, and hospitals are unable to manage their human resources or reallocate funds between cost categories without first requesting approvals from the Ministry of Health (MOH) and Ministry of Finance (MOF). Savings at the end of the fiscal year (December) are automatically returned to MOF, discouraging hospital managers from pursuing efficiency gains. Such systemic issues limit effective and efficient hospital treatment as the COVID-19 pandemic continues. Reform area 2 includes several policy actions that will strengthen existing governance arrangements in the health sector. Another area that leads to inefficient governance arrangements in the health sector is the absence of an effectively regulated pharmaceutical sector.
Expensive and poor-quality medicines, and their inappropriate use, affect health security. The prevalence of substandard (10.1%), unregistered (4.3%), and falsified (0.8%) medicines in Mongolia is one of the highest in the world. Pharmaceutical regulation is also highly fragmented. Functions such as licensing and registration, pricing, quality control, market surveillance and control, inspection and enforcement, implementation of an integrated regulatory information system, and enforcing rational drug use are implemented by different agencies instead of one single drug regulatory authority, leading to poor coordination and increased inefficiencies. Pharmaceutical regulation inefficiencies also create significant constraints as Mongolia prepares to rollout COVID-19 vaccines. The procurement of medicines in public hospitals is also decentralized, with each hospital being responsible for its own purchasing and drug budgets. This system increases unit costs of medicines in public hospitals and leads to quality and efficiency constraints in the pharmaceutical sector, which affects health security. Procurement efficiency gains and better pharmaceutical regulation in the health sector need to be addressed through various policy reforms.
Health financing constraints amplified during pandemics. There are three main sources of health financing: (i) state budget, (ii) social health insurance, and (iii) out-of-pocket expenditure (OPE). This multi-payer system creates inefficiencies and increases administrative costs. In addition, although 90% of the population is covered by social health insurance, the benefit package is limited, with social health insurance covering mainly inpatient services. Because of the gaps in service coverage, OPE accounts for 32% of total health costs, of which one-third are for medicines, because of high prices and inappropriate use. This inadequate and inefficient financing system leads to higher health system costs and hinders Mongolia's ability to respond to the COVID-19 pandemic. Several policy reforms are needed to significantly streamline financing arrangements in the health sector.
|Impact||Health outcomes in Mongolia improved|
|Description of Outcome||Quality and delivery of health services improved|
|Progress Toward Outcome||The Government is undertaking reform measures (i) strengthening health sector preparedness and response to the COVID-19 pandemic; (ii) improving the governance of the health sector operations; (iii) improving sustainability and efficiency of health sector resources; and (iv) enhancing medium-term fiscal stability. The Government has updated Health Sector Disaster Response Plan and introduced integrated incident management system to ensure COVID-19 response measures are coordinated and resources are efficiency utilized. Moreover, the Government has take health sector reform measures towards improving the quality and availability of drugs and medical supplies, strengthening health services through increased hospital autonomy, and improving performance based health sector financing schemes.|
|Description of Project Outputs|
|Status of Implementation Progress (Outputs, Activities, and Issues)||In April 2021, ADB provided to the Government of Mongolia $100 million from ordinary capital resources|
|Summary of Environmental and Social Aspects|
|Environmental Aspects||No adverse environmental impacts under ADB's Safeguard Policy Statement (2009) have been identified.|
|Involuntary Resettlement||No adverse involuntary resettlement impacts under ADB's Safeguard Policy Statement (2009) have been identified.|
|Indigenous Peoples||No adverse indigenous peoples impacts under ADB's Safeguard Policy Statement (2009) have been identified.|
|Stakeholder Communication, Participation, and Consultation|
|During Project Design||Program preparation involved consultation with key stakeholders.|
|During Project Implementation||The stakeholders will continuously be engaged during the implementation.|
|Consulting Services||Engagement of consulting services is not envisaged.|
|Procurement||Procurement of goods and works is not envisaged.|
|Responsible ADB Officer||Jigjidsuren, Altantuya|
|Responsible ADB Department||East Asia Department|
|Responsible ADB Division||Mongolia Resident Mission|
Ministry of Finance (formerly Ministry of Finance and Economy)
Ministry of Finance
S.Danzangiin Gudamj 5/1, Zasgiin Gazriin
II Bair, Ulaanbaatar 15160 Mongolia
|Concept Clearance||11 Mar 2022|
|Fact Finding||01 Sep 2020 to 06 Oct 2020|
|MRM||22 Jan 2021|
|Approval||30 Mar 2021|
|Last Review Mission||-|
|Last PDS Update||30 Sep 2021|
|Approval||Signing Date||Effectivity Date||Closing|
|30 Mar 2021||01 Apr 2021||08 Apr 2021||14 May 2021||-||22 Oct 2021|
|Financing Plan||Loan Utilization|
|Total (Amount in US$ million)||Date||ADB||Others||Net Percentage|
|Project Cost||100.00||Cumulative Contract Awards|
|ADB||100.00||17 Jun 2022||100.00||0.00||100%|
|Cofinancing||0.00||17 Jun 2022||100.00||0.00||100%|
Project Data Sheets (PDS) contain summary information on the project or program. Because the PDS is a work in progress, some information may not be included in its initial version but will be added as it becomes available. Information about proposed projects is tentative and indicative.
The Access to Information Policy (AIP) recognizes that transparency and accountability are essential to development effectiveness. It establishes the disclosure requirements for documents and information ADB produces or requires to be produced.
The Accountability Mechanism provides a forum where people adversely affected by ADB-assisted projects can voice and seek solutions to their problems and report alleged noncompliance of ADB's operational policies and procedures.
In preparing any country program or strategy, financing any project, or by making any designation of, or reference to, a particular territory or geographic area in this document, the Asian Development Bank does not intend to make any judgments as to the legal or other status of any territory or area.
|Title||Document Type||Document Date|
|Loan Agreement (Ordinary Operations) for Loan 4056-MON: Strengthening Health Security Program (Subprogram 1)||Loan Agreement (Ordinary Resources)||Apr 2021|
|Strengthening Health Security Program (Subprogram 1): Gender Action Plan||Gender Action Plans||Mar 2021|
|Strengthening Health Security Program (Subprogram 1): Report and Recommendation of the President||Reports and Recommendations of the President||Mar 2021|
Safeguard Documents See also: Safeguards
Safeguard documents provided at the time of project/facility approval may also be found in the list of linked documents provided with the Report and Recommendation of the President.
None currently available.
Evaluation Documents See also: Independent Evaluation
None currently available.
None currently available.
The Access to Information Policy (AIP) establishes the disclosure requirements for documents and information ADB produces or requires to be produced in its operations to facilitate stakeholder participation in ADB's decision-making. For more information, refer to the Safeguard Policy Statement, Operations Manual F1, and Operations Manual L3.
Requests for information may also be directed to the InfoUnit.
ADB’s Response to Mitigate COVID-19 Impacts in MongoliaADB is helping Mongolia to mitigate severe health and economic impacts of COVID-19 by improving preparedness and response, delivering much-needed medical equipment and supplies, and supporting the government’s social protection measures.
ADB to Help Strengthen Mongolia’s Health Sector and Response to COVID-19The Asian Development Bank approved today a $100 million loan to strengthen Mongolia’s health sector and its response to the coronavirus disease (COVID-19) pandemic.
No tenders for this project were found.
No contracts awarded for this project were found
None currently available.